Global Thyrogen Data 2025, Forecast To 2034
7 Mar, 2025
How Has the Thyrogen Market Size Evolved in Recent Years?
The thyrogen market has seen considerable growth due to a variety of factors.
• The market size of Thyrogen has been significantly expanding in the past years. Expectedly, it will further expand from $1,080 million in 2024 to $1,170 million in 2025, registering a compound annual growth rate (CAGR) of 8.6%.
The driving forces of this growth from the historical period include the reduced spending in healthcare, increased simplicity of use, the rise of telemedicine, amplified use of breast cancer treatments, the growing adoption of Thyrogen, and a heightened demand for the treatment of thyroid cancer.
What Are The Predictions for The Thyrogen Market in the Coming Years?
The thyrogen market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the thyrogen market size is anticipated to experience significant growth. The projected growth is estimated to hit $1,610 million by 2029 with a compound annual growth rate (CAGR) of 8.3%.
Factors contributing to this anticipated growth in the forecast period include a heightened incidence of thyroid cancer, an increased emphasis on patient-focused healthcare, a surge in awareness and diagnosis of thyroid-related issues, a rise in cases of anaplastic thyroid cancer, and improved awareness and education. The forecast period is also expected to be characterized by advancements in diagnostic technologies, technological innovation in treatments, launch of new products, groundbreaking oncology medications, and progression in biotechnology.
Which Drivers Are Accelerating Growth In The Thyrogen Market?
The growth of the thyrogen market is slated to accelerate due to the rising prevalence of thyroid cancer. Originating in the thyroid gland, this type of cancer often manifests as a neck nodule or lump. Temperature changes, radiation exposure, and advanced biopsy and imaging techniques are primarily causing the surge in thyroid cancer prevalence. Thyrogen, by stimulating the thyroid gland, aids in detecting residual cancer and boosts the efficiency of radioactive iodine therapy in treating thyroid cancer. Furthermore, the American Cancer Society, a professional organization based in the U.S., approximated that the new cases of thyroid cancer are expected to rise to 44,020 in January 2024 from 43,720 in 2023. This count includes 12,500 men and 31,520 women. Also, approximately 2,170 thyroid cancer-related deaths are foreseen, with 990 men and 1,180 women contributing to the count. Thus, with the mounting prevalence of thyroid cancer, the thyrogen market is experiencing significant growth. Personalized medicine is another prime factor fueling the growth of the thyrogen market. Personalized medicine is healthcare customized to each patient's unique lifestyle, genetic, and environmental factors. This approach results in superior patient care and minimises adverse effects as it delivers accurate healthcare outcomes. In the realm of precision medicine, thyrogen plays a crucial role in providing tailored diagnostic and therapeutic interventions, specifically for patients with differentiated thyroid cancer resistant to radioiodine, by activating thyroid-stimulating hormone receptors. The Personalized Medicine Coalition, a U.S.-based organization, published a report in February 2024 indicating that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant rise from six approvals in 2022. These new personalized treatments comprised seven cancer drugs and three therapies for other ailments and conditions. Thus, this growing emphasis on personalized medicine is steering the progress of the thyrogen market.
What Are The Core Segments Of The Global Thyrogen Market?
The thyrogen market covered in this report is segmented –
1) By Type: Vail, Pre-Filled
2) By Product Type: Thyrogen Powder, Thyrogen Injection
3) By Application: Diagnostic, Therapeutic
4) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Other End-Users
Which Emerging Trends Are Reshaping The Thyrogen Market Size?
The prevailing movement within the thyrogen market is the development of inventive applications, notably as a theranostic tool for the diagnosis and treatment of differentiated thyroid cancer. This strategic focus opens up avenues for companies to increase their market footprint while satisfying overlooked requirements in the field of oncology. Thyrogen, in its capacity as a theranostic tool, facilitates both diagnostic imaging and therapeutic applications for differentiated thyroid cancer, chiefly in patients with a resistance to radioiodine. Its method is through the targeted interaction with thyroid-stimulating hormone receptors. As an example, in June 2024, the Society of Nuclear Medicine and Molecular Imaging, a professional organization from the U.S, published a research article in the Journal of Nuclear Medicine. The research pertained to the expansion of clinical applications via an advanced theranostic approach, including exploring the potential of diagnosing and treating radioiodine-resistant differentiated thyroid cancer (DTC) utilizing Thyrogen as a targeted radiopharmaceutical, for instance, [89Zr]Zr-Thyrogen. This development emphasises the transition towards precision medicine which customises diagnostic and therapeutic interventions to a patient's particular needs. Furthermore, continual investment and innovation in research endorse the use of recombinant TSH for addressing unmet medical necessities, propelling its use in nascent clinical settings.
Who Are the Key Players In The Thyrogen Market?
Major companies operating in the thyrogen market include:
• Sanofi S.A.
What Are The Regional Insights Into The Thyrogen Market?
North America was the largest region in the thyrogen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyrogen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.